Acquisition leverages Cadence’s computational software expertise into molecular modeling and simulation, focused on pharmaceutical and biotechnology…

Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a survival…

Snorkel AI, the data-centric AI platform company, announced that it is hosting the second annual The Future of Data-Centric AI conference for leaders…

Reltio, the leading cloud-native, SaaS MDM company that accelerates the value of data for businesses, announced multiple new capabilities within…

Box, Inc. the leading Content Cloud, announced that Clario has chosen Box as its single, integrated solution to centralize regulated and unregulated…

DCVC and Magnetic Ventures co-led a $25 million seed financing, with participation from Khosla Ventures, OMERS Ventures, and firstminute Capital,…

Anifrolumab is a first-in-class type I interferon receptor antibody The first patients have been dosed in the IRIS Phase III clinical trial of…

ENHERTU data from historic DESTINY-Breast04 trial in patients with HER2 low metastatic breast cancer has the potential to redefine how breast…

Nintex, the global standard for process intelligence and automation, announced that Aragon Research has named the company a leader in The Aragon…

Sinequa, a leading Search Cloud provider, further strengthened its integration with Microsoft by enabling its customers to easily procure Sinequa’s…